CASI Pharmaceuticals, Inc. (CASI)

NASDAQ: CASI · IEX Real-Time Price · USD

2.420

+0.120 (5.22%)

At close: Apr 26, 2024, 4:00 PM

2.390

-0.030 (-1.24%)

After-hours: Apr 26, 2024, 4:21 PM EDT

CASI Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1994
Net Income	-26.96	-41.01	-36.65	-48.29	-46.03	-27.47	-10.77	-9.45	-7.21	-26.2	Upgrade
Depreciation & Amortization	4.73	3.61	3.1	3.23	2.58	1.67	0.12	0.07	0.07	0.05	Upgrade
Share-Based Compensation	7.22	7.01	7.77	7.82	7.31	6.12	0.65	3	1.54	2.19	Upgrade
Other Operating Activities	-4.98	9.31	-1.05	11.35	12.9	-8.9	3.6	0.37	0.08	19.97	Upgrade
Operating Cash Flow	-19.97	-21.09	-26.84	-25.89	-23.24	-28.58	-6.4	-6.02	-5.51	-4	Upgrade
Capital Expenditures	-2.24	-5.47	-8.94	1.2	-7.05	-1.13	-0.93	-0.06	-0.03	-0.23	Upgrade
Acquisitions	0	41.16	-5.68	-6.4	-14.04	-20.64	0	0	0	0	Upgrade
Change in Investments	-7.43	-4.53	0	0	0	0	0	0	0	0	Upgrade
Other Investing Activities	-	-	-6.08	-15.52	-6.97	-	-	-	-	-0.23	Upgrade
Investing Cash Flow	-9.67	31.16	-20.69	-20.72	-28.06	-21.77	-0.93	-0.06	-0.03	-0.47	Upgrade
Share Issuance / Repurchase	-0.17	-3.27	30.48	45.9	3.75	92.27	23.73	28.05	0	0	Upgrade
Debt Issued / Paid	0	0	-0.84	1.25	-1.5	0	0	0	0	0	Upgrade
Other Financing Activities	-0.74	-	-	-	19.79	-	-	-	-	-	Upgrade
Financing Cash Flow	-0.91	-3.27	29.64	47.15	22.05	92.27	23.73	28.05	0	0	Upgrade
Exchange Rate Effect	0.52	1.6	-0.47	2.9	-1.33	-1.2	0	0	0	0	Upgrade
Net Cash Flow	-30.03	8.41	-18.36	3.44	-30.58	40.72	16.4	21.96	-5.54	-4.46	Upgrade
Free Cash Flow	-22.21	-26.56	-35.78	-24.69	-30.3	-29.71	-7.34	-6.09	-5.54	-4.23	Upgrade
Free Cash Flow Margin	-65.55%	-61.62%	-118.59%	-163.03%	-733.38%	-	-	-	-11608.83%	-17816.18%	Upgrade
Free Cash Flow Per Share	-1.66	-1.95	-2.63	-2.23	-3.16	-3.51	-1.19	-1.09	-1.71	-1.48	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).